109 related articles for article (PubMed ID: 38750702)
1. IGF-1 gene therapy prevents spatial memory deficits and modulates dopaminergic neurodegeneration and inflammation in a parkinsonism model.
Herrera ML; Champarini LG; Basmadjian OM; Bellini MJ; Hereñú CB
Brain Behav Immun; 2024 Jul; 119():851-866. PubMed ID: 38750702
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I gene therapy increases hippocampal neurogenesis, astrocyte branching and improves spatial memory in female aging rats.
Pardo J; Uriarte M; Cónsole GM; Reggiani PC; Outeiro TF; Morel GR; Goya RG
Eur J Neurosci; 2016 Aug; 44(4):2120-8. PubMed ID: 27188415
[TBL] [Abstract][Full Text] [Related]
3. Early Cognitive Impairment Behind Nigrostriatal Circuit Neurotoxicity: Are Astrocytes Involved?
Herrera ML; Deza-Ponzio R; Ghersi MS; de la Villarmois EA; Virgolini MB; Pérez MF; Molina VA; Bellini MJ; Hereñú CB
ASN Neuro; 2020; 12():1759091420925977. PubMed ID: 32466659
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases.
Ayadi AE; Zigmond MJ; Smith AD
Exp Brain Res; 2016 Jul; 234(7):1863-1873. PubMed ID: 26894890
[TBL] [Abstract][Full Text] [Related]
5. Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit.
Belloso-Iguerategui A; Zamarbide M; Merino-Galan L; Rodríguez-Chinchilla T; Gago B; Santamaria E; Fernández-Irigoyen J; Cotman CW; Prieto GA; Quiroga-Varela A; Rodríguez-Oroz MC
Brain; 2023 Dec; 146(12):4949-4963. PubMed ID: 37403195
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
7. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease.
Zhang S; Wang XJ; Tian LP; Pan J; Lu GQ; Zhang YJ; Ding JQ; Chen SD
J Neuroinflammation; 2011 Nov; 8():154. PubMed ID: 22053982
[TBL] [Abstract][Full Text] [Related]
8. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
9. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Domin H; Śmiałowska M; Głowacka U; Ossowska K
Neuroscience; 2016 Feb; 314():22-34. PubMed ID: 26628402
[TBL] [Abstract][Full Text] [Related]
10. Novel Food Supplement "CP1" Improves Motor Deficit, Cognitive Function, and Neurodegeneration in Animal Model of Parkinson's Disease.
Wattanathorn J; Sutalangka C
Rejuvenation Res; 2016 Aug; 19(4):273-85. PubMed ID: 26414358
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of garlic extract on dopaminergic neurons of substantia nigra in a rat model of Parkinson's disease: motor and non-motor outcomes.
Bigham M; Mohammadipour A; Hosseini M; Malvandi AM; Ebrahimzadeh-Bideskan A
Metab Brain Dis; 2021 Jun; 36(5):927-937. PubMed ID: 33656625
[TBL] [Abstract][Full Text] [Related]
12. Intracranial application of near-infrared light in a hemi-parkinsonian rat model: the impact on behavior and cell survival.
Reinhart F; Massri NE; Chabrol C; Cretallaz C; Johnstone DM; Torres N; Darlot F; Costecalde T; Stone J; Mitrofanis J; Benabid AL; Moro C
J Neurosurg; 2016 Jun; 124(6):1829-41. PubMed ID: 26613166
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway.
Xu L; Chen WF; Wong MS
Br J Pharmacol; 2009 Oct; 158(3):738-48. PubMed ID: 19703168
[TBL] [Abstract][Full Text] [Related]
14. IGF-1 Gene Transfer Modifies Inflammatory Environment and Gene Expression in the Caudate-Putamen of Aged Female Rat Brain.
Falomir-Lockhart E; Dolcetti FJC; Herrera ML; Pennini J; Zappa Villar MF; Salinas G; Portiansky E; Spittau B; Lacunza E; Hereñú CB; Bellini MJ
Mol Neurobiol; 2022 Jun; 59(6):3337-3352. PubMed ID: 35306642
[TBL] [Abstract][Full Text] [Related]
15. Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson's Disease.
Hsueh SC; Chen KY; Lai JH; Wu CC; Yu YW; Luo Y; Hsieh TH; Chiang YH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419747
[TBL] [Abstract][Full Text] [Related]
16. The effect of preventive exercise on the neuroprotection in 6-hydroxydopamine-lesioned rat brain.
Rezaee Z; Marandi SM; Alaei H; Esfarjani F
Appl Physiol Nutr Metab; 2019 Dec; 44(12):1267-1275. PubMed ID: 31691583
[TBL] [Abstract][Full Text] [Related]
17. Long-term protective effects of AAV9-mesencephalic astrocyte-derived neurotrophic factor gene transfer in parkinsonian rats.
Hao F; Yang C; Chen SS; Wang YY; Zhou W; Hao Q; Lu T; Hoffer B; Zhao LR; Duan WM; Xu QY
Exp Neurol; 2017 May; 291():120-133. PubMed ID: 28131727
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats.
Singh S; Mishra A; Srivastava N; Shukla R; Shukla S
Mol Neurobiol; 2018 Jan; 55(1):583-602. PubMed ID: 27975173
[TBL] [Abstract][Full Text] [Related]
19. L-alpha-aminoadipic acid restricts dopaminergic neurodegeneration and motor deficits in an inflammatory model of Parkinson's disease in male rats.
O'Neill E; Chiara Goisis R; Haverty R; Harkin A
J Neurosci Res; 2019 Jul; 97(7):804-816. PubMed ID: 30924171
[TBL] [Abstract][Full Text] [Related]
20. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease.
Azzouz M; Martin-Rendon E; Barber RD; Mitrophanous KA; Carter EE; Rohll JB; Kingsman SM; Kingsman AJ; Mazarakis ND
J Neurosci; 2002 Dec; 22(23):10302-12. PubMed ID: 12451130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
